GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.0837
-0.0037 (-4.23%)
Oct 2, 2026, 5:35 PM CET

GenSight Biologics Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.672.422.462.1310.6144.29
Cash & Short-Term Investments
1.672.422.462.1310.6144.29
Cash Growth
519.26%-1.99%15.46%-79.89%-76.04%16.72%
Accounts Receivable
--00-0.75
Other Receivables
-1.581.992.43.493.54
Receivables
-1.581.992.43.494.3
Prepaid Expenses
-0.150.281.638.212.55
Other Current Assets
2.50.840.610.370.632.23
Total Current Assets
4.174.985.346.5322.9553.36
Property, Plant & Equipment
0.290.430.932.032.272.55
Other Intangible Assets
--0.060.080.090.11
Other Long-Term Assets
2.022.854.420.50.630.62
Total Assets
6.488.2610.769.1325.9456.65

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.415.926.365.637.8111.56
Accrued Expenses
-2.141.731.793.612.45
Current Portion of Long-Term Debt
3.363.313.3116.611.544.68
Current Portion of Leases
0.180.350.590.780.890.74
Current Income Taxes Payable
-0.250.170.030.030.02
Current Unearned Revenue
---0.070.030.2
Other Current Liabilities
2.880.720.460.40.732.6
Total Current Liabilities
11.8312.6722.6225.2914.6422.24
Long-Term Debt
9.299.22-5.1114.4610.58
Long-Term Leases
-00.511.050.971.51
Long-Term Unearned Revenue
----0.190.42
Pension & Post-Retirement Benefits
-1.11.171.260.020.04
Other Long-Term Liabilities
18.9610.213.387.1310.935.86
Total Liabilities
40.0833.237.6839.8341.2240.66

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
5.895.523.121.631.161.16
Additional Paid-In Capital
218.63217.41206.61190.94181.21181.18
Retained Earnings
-10.27-12.04-14-26.22-27.63-28.62
Comprehensive Income & Other
-247.85-235.83-222.64-197.05-170.02-137.73
Shareholders' Equity
-33.6-24.94-26.92-30.7-15.2815.99
Total Liabilities & Equity
6.488.2610.769.1325.9456.65

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
12.8412.8614.4123.5417.8617.51
Net Cash (Debt)
-11.17-10.45-11.95-21.4-7.2526.78
Net Cash Growth
-----42.36%
Net Cash Per Share
-0.06-0.07-0.12-0.44-0.160.59
Filing Date Shares Outstanding
205.42220.32128.1564.9746.1846.24
Total Common Shares Outstanding
205.42220.32128.1564.9746.1846.24
Working Capital
-7.66-7.69-17.28-18.768.3131.12
Book Value Per Share
-0.16-0.11-0.21-0.47-0.330.35
Tangible Book Value
-33.6-24.94-26.98-30.78-15.3715.88
Tangible Book Value Per Share
-0.16-0.11-0.21-0.47-0.330.34
Machinery
-1.231.231.231.221.36
Leasehold Improvements
-1.311.381.351.370.98